Martens et al., 1990 - Google Patents
Importance of enantiomeric purity and its control by thin-layer chromatographyMartens et al., 1990
- Document ID
- 10140501548276848521
- Author
- Martens J
- Bhushan R
- Publication year
- Publication venue
- Journal of pharmaceutical and biomedical analysis
External Links
Snippet
Methods for the direct resolution of enantiomers are important and are necessary for pharmaceutical and biomedical analysis, synthetic and mechanistic studies and various other fields. The present paper deals with the results of recent approaches, such as ligand …
- 238000004809 thin layer chromatography 0 title abstract description 5
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8665—Signal analysis for calibrating the measuring apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- G01N30/94—Development
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chankvetadze | Application of enantioselective separation techniques to bioanalysis of chiral drugs and their metabolites | |
| Günther | Thin-layer chromatographic enantiomeric resolution via ligand exchange | |
| Owens et al. | Molecular imprinting for bio-and pharmaceutical analysis | |
| León‐González et al. | Two‐dimensional liquid chromatography for direct chiral separations: a review | |
| Ilisz et al. | State-of-the-art enantioseparations of natural and unnatural amino acids by high-performance liquid chromatography | |
| Ekborg‐Ott et al. | Highly enantioselective HPLC separations using the covalently bonded macrocyclic antibiotic, ristocetin A, chiral stationary phase | |
| Scriba | Pharmaceutical and biomedical applications of chiral capillary electrophoresis and capillary electrochromatography: An update | |
| Martens et al. | Importance of enantiomeric purity and its control by thin-layer chromatography | |
| Wainer | Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid chromatographic chiral stationary phases | |
| Carenzi et al. | Direct chromatographic methods for enantioresolution of amino acids: Recent developments | |
| Haginaka | Pharmaceutical and biomedical applications of enantioseparations using liquid chromatographic techniques | |
| Gika et al. | Direct separation and quantitative analysis of thyroxine and triiodothyronine enantiomers in pharmaceuticals by high-performance liquid chromatography | |
| Tanwar et al. | Enantioresolution of amino acids: a decade’s perspective, prospects and challenges | |
| Sanchez-Hernandez et al. | Enantiomeric separation of free L-and D-amino acids in hydrolyzed protein fertilizers by capillary electrophoresis tandem mass spectrometry | |
| Arai | Chiral separation of pharmaceuticals possessing a carboxy moiety | |
| Horak et al. | Derivatize, racemize, and analyze—an easy and simple procedure for chiral amino acid standard preparation for enantioselective metabolomics | |
| Bhushan et al. | Direct resolution of enantiomers by impregnated TLC | |
| Martens et al. | TLC enantiomeric separation of amino acids | |
| Inoue et al. | Determination of minute amounts of D-leucine in various brain regions of rat and mouse using column-switching high-performance liquid chromatography | |
| Hellinger et al. | Enantioseparation of 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate tagged amino acids and other zwitterionic compounds on cinchona-based chiral stationary phases | |
| Aboul‐Enein et al. | Application of thin‐layer chromatography in enantiomeric chiral analysis—an overview | |
| Jaworska et al. | New approach for amino acid profiling in human plasma by selective fluorescence derivatization | |
| Martens et al. | Direct thin layer chromatographic enantioseparation of active pharmaceutical ingredients via non-covalent diastereomers | |
| Badgujar et al. | Enantiomeric purity of synthetic therapeutic peptides: A review | |
| Kırkan et al. | Free amino acid analysis in honey samples by hydrophilic interaction liquid chromatography with UV detection using precolumn derivatization with dansyl chloride |